СИМДАКС на ресурсе PubMed

1. Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Birhan Yilmaz M, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A,

Eur Heart J

PubMed:30295807

 

2. Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy.

Kırış T, Avcı E

J Clin Ultrasound

PubMed:30229927

 

3. Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.

Ng KT, Chan XL, Tan W, Wang CY

J Clin Anesth

PubMed:30172838

 

4. Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience.

Wang C, Gong J, Shi S, Wang J, Gao Y, Wang S, Peng YG, Song J, Wang Y

Front Pediatr

PubMed:30155453

 

5. Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.

Oliva F, Perna E, Marini M, Nassiacos D, Cirò A, Malfatto G, Morandi F, Caico I, Perna G, Meloni S, Vincenzi A, Villani A, Vecchi AL, Minoia C, Verde A, De Maria R, RELEVANT-HF study group.

Int J Cardiol

PubMed:30131229

 

6. Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.

Poidinger B, Kotzinger O, Rützler K, Kleinsasser A, Zierer A, Knotzer H

J Cardiothorac Vasc Anesth

PubMed:30122612